D75.81
Myelofibrosis
Clinical Classification Guidelines
Use Additional Code
- code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
Inclusion Terms
- Myelofibrosis NOS
- Secondary myelofibrosis NOS
Excludes Type 1
- acute myelofibrosis (C94.4-)
- idiopathic myelofibrosis (D47.1)
- leukoerythroblastic anemia (D61.82)
- myelofibrosis with myeloid metaplasia (D47.4)
- myelophthisic anemia (D61.82)
- myelophthisis (D61.82)
- primary myelofibrosis (D47.1)
Code First
- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
Medical Intelligence & Overview
Myelofibrosis is a rare type of blood disorder characterized by the gradual replacement of healthy bone marrow tissue with fibrous (scar) tissue. This process impairs the production of blood cells, leading to a range of health issues. When myelofibrosis occurs without a known cause, it is referred to as primary myelofibrosis. If it develops as a complication of another disease or condition, it is called secondary myelofibrosis. This guide aims to provide a clear understanding of myelofibrosis, its causes, symptoms, diagnosis, and general treatment approaches.
Causes & Symptoms
Clinical Causes: Primary myelofibrosis develops due to genetic mutations in the bone marrow cells, often involving the JAK2, CALR, or MPL genes. Secondary myelofibrosis can develop as a consequence of other marrow disorders, such as polycythemia vera or essential thrombocythemia. Exposure to certain environmental toxins or previous radiation therapy may play a role, though these are less common causes.
Key Symptoms: Fatigue and weakness Swelling or pain in the abdomen due to an enlarged spleen or liver Unintended weight loss Fever or night sweats Bone pain or tenderness Frequent infections due to decreased normal blood cells Bleeding or easy bruising Shortness of breath Pale skin due to anemia
Diagnostic & Treatment
Diagnosis Path: Diagnosing myelofibrosis involves a combination of medical history assessment, physical examination, blood tests, and bone marrow analysis. Typically, tests include:
Treatment Protocols: While there is no cure for myelofibrosis, various treatments can help manage symptoms and improve quality of life. Therapeutic options depend on disease severity and patient health status:
Clinical Advice & FAQs
Billing Guidance
Is D75.81 a billable ICD-10 code?
Yes, D75.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D75.81?
Clinical documentation must specify the nature of Myelofibrosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference